“I lacked understanding of the internal processes in Big Pharma”
Many people dream of it, but few have actually tried it in Denmark – selling something to Big Pharma. There is one crucial factor if you want to increase your chances, says Allan Jensen, who has worked for the Danish biotech company Symphogen and the US drug giant Pfizer.
BY BENJAMIN WERNER CHRISTENSEN
For a Danish biotech company to be able to sell a project or the entire company to a Big Pharma player, it is important to be familiar with the internal processes in major corporations, says Alan Jensen.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
